Related Experiment Video
Updated: Jun 11, 2025
10:39
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
7.6K
Chimeric Antigen-LgDNA Nanoparticles Attenuate Airway Th2 Polarization
Ruien Chen1, Huamei Zou1, Xiuwen Ye1
1Department of Otolaryngology, Longgang Central Hospital and Guangzhou University of Chinese Traditional Medicine Shenzhen Clinical College, Shenzhen, 518116, People's Republic of China.
International Journal of Nanomedicine
|October 2, 2024
Summary
Chimeric antigen-LgDNA nanoparticles (CAP-NPs) were developed to treat airway allergies. These CAP-NPs induce apoptosis in antigen-specific CD4+ T cells, effectively reducing Th2 polarization and improving therapeutic outcomes.
Area of Science:
- Immunology
- Nanotechnology
- Allergy Research
Background:
- Airway allergies are a growing concern, with Th2 polarization being a key pathological feature.
- Current therapeutic strategies for airway allergies require improvement.
Purpose of the Study:
- To develop novel nanoparticles for treating airway allergies.
- To investigate the efficacy of chimeric antigen-LgDNA nanoparticles (CAP-NPs) in modulating Th2 polarization.
Main Methods:
- Constructed disulfide bond-linked antigen-major histocompatibility complex II (MHC II)-LgDNA nanoparticles (CAP-NPs).
- Established a mouse model of airway Th2 polarization to evaluate CAP-NP effects.
- Utilized in vitro assays to assess CAP-NP interaction with CD4+ T cells and apoptosis induction.
Main Results:
- CAP-NPs were confirmed to contain ovalbumin (OVA), MHC II, and LgDNA, and remained stable.
- In vitro, CAP-NPs induced apoptosis in OVA-specific CD4+ T cells by upregulating KDM5A, leading to caspase 8 activation.
- Administration of CAP-NPs significantly alleviated experimental airway Th2 polarization.
Conclusions:
- Developed CAP-NPs capable of inducing antigen-specific CD4+ T cell apoptosis.
- CAP-NPs demonstrate significant potential in alleviating airway Th2 polarization, offering a promising therapeutic approach for airway allergies.
